Abstract:Since the reproductive toxicity of COVID‐19 vaccines have not been assessed in previous clinical trials, and studies have shown that SARS‐CoV‐2 is associated with a decrease in sperm parameters. Although it has been reported that the mRNA SARS‐CoV‐2 vaccines do not adversely affect semen parameters, whether this conclusion applies to inactivated vaccines remains unclear. Here, we conducted a study among patients who accepted in vitro fertilization (IVF) at the reproductive centre between June and August of 202… Show more
“…Thus, it is necessary to evaluate any effect of inactivated SARS‐CoV‐2 vaccination on male fertility. During our long study period (almost 16 months), several studies exploring the effects of inactivated SARS‐CoV‐2 vaccination on semen parameters have been published 30,31 . Compared to them, our study expanded the sample size and collection time, and included booster dose and sex hormone levels for the first time.…”
Numerous studies have revealed severe damage to male fertility from severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, raising concerns about the potential adverse impact on reproductive function of the coronavirus disease 2019 (COVID‐19) vaccine developed based on the virus. Interestingly, there are several researchers who have studied the impact of the COVID‐19 mRNA vaccine since then but have come up with conflicting results. As a near‐ideal candidate for mass immunization programs, inactivated SARS‐CoV‐2 vaccine has been widely used in many countries, particularly in less wealthy nations. However, little is known about its effect on male fertility. Here, we conducted a retrospective cohort study at a single large center for reproductive medicine in China between December 2021 and August 2022. Five hundred and nineteen fertile men with no history of laboratory‐confirmed COVID‐19 were included and categorized into four groups based on their vaccination status: unvaccinated group (n = 168), one‐dose vaccinated group (n = 8), fully vaccinated group (n = 183), and booster group (n = 160). All of them underwent a semen analysis and most had serum sex hormone levels tested. There were no significant differences in all semen parameters and sex hormone levels between the unvaccinated group and either vaccinated group. To account for possible vaccination‐to‐test interval‐specific changes, sub‐analyses were performed for two interval groups: ≤90 and >90 days. As expected, most of the semen parameters and sex hormone levels remained unchanged between the control and vaccinated groups. However, participants in vaccinated group (≤90 days) have decreased total sperm motility and increased follicle‐stimulating hormone level compared with the ones in unvaccinated group. Moreover, some trends similar to those found during COVID‐19 infection and recovery were observed in our study. Fortunately, all values are within the normal range. In addition, vaccinated participants reported few adverse reactions. No special medical intervention was required, and no serious adverse reactions happened. Our study suggests that inactivated SARS‐CoV‐2 vaccination does not impair male fertility, possibly due to the low frequency of adverse effects. This information reassures young male population who got this vaccine worldwide, and helps guide future vaccination efforts.
“…Thus, it is necessary to evaluate any effect of inactivated SARS‐CoV‐2 vaccination on male fertility. During our long study period (almost 16 months), several studies exploring the effects of inactivated SARS‐CoV‐2 vaccination on semen parameters have been published 30,31 . Compared to them, our study expanded the sample size and collection time, and included booster dose and sex hormone levels for the first time.…”
Numerous studies have revealed severe damage to male fertility from severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, raising concerns about the potential adverse impact on reproductive function of the coronavirus disease 2019 (COVID‐19) vaccine developed based on the virus. Interestingly, there are several researchers who have studied the impact of the COVID‐19 mRNA vaccine since then but have come up with conflicting results. As a near‐ideal candidate for mass immunization programs, inactivated SARS‐CoV‐2 vaccine has been widely used in many countries, particularly in less wealthy nations. However, little is known about its effect on male fertility. Here, we conducted a retrospective cohort study at a single large center for reproductive medicine in China between December 2021 and August 2022. Five hundred and nineteen fertile men with no history of laboratory‐confirmed COVID‐19 were included and categorized into four groups based on their vaccination status: unvaccinated group (n = 168), one‐dose vaccinated group (n = 8), fully vaccinated group (n = 183), and booster group (n = 160). All of them underwent a semen analysis and most had serum sex hormone levels tested. There were no significant differences in all semen parameters and sex hormone levels between the unvaccinated group and either vaccinated group. To account for possible vaccination‐to‐test interval‐specific changes, sub‐analyses were performed for two interval groups: ≤90 and >90 days. As expected, most of the semen parameters and sex hormone levels remained unchanged between the control and vaccinated groups. However, participants in vaccinated group (≤90 days) have decreased total sperm motility and increased follicle‐stimulating hormone level compared with the ones in unvaccinated group. Moreover, some trends similar to those found during COVID‐19 infection and recovery were observed in our study. Fortunately, all values are within the normal range. In addition, vaccinated participants reported few adverse reactions. No special medical intervention was required, and no serious adverse reactions happened. Our study suggests that inactivated SARS‐CoV‐2 vaccination does not impair male fertility, possibly due to the low frequency of adverse effects. This information reassures young male population who got this vaccine worldwide, and helps guide future vaccination efforts.
“…In detail, five studies retrospectively analyzed the potential impact of COVID-19 vaccine (both mRNA, inactivated and viral vector ones) on sperm parameters, three of them in men undergoing fertility treatments ( 94 , 96 , 100 ) and two in healthy semen donors ( 99 , 101 ). Overall, sperm parameters showed no significant changes after vaccination, except a slight decrease in sperm volume observed by Safrai et al.…”
PurposeThe purpose of this study was to describe the current knowledge on the potential endocrine adverse effects post-COVID-19 vaccines.MethodsA PubMed/MEDLINE, Web of Science, and Scopus research was performed. Case reports, case series, original studies, and reviews written in English and published online up to 31 July 2022 were selected and reviewed. The final reference list was defined based on the relevance of each paper to the scope of this review.ResultsThe available data showed that endocrine side effects are generally rare and with favorable outcome, being thyroid disorders the most common. Conversely, data on type 1 diabetes mellitus are rare; adrenal and pituitary events are even anecdotal. Finally, the available clinical studies suggest no impact on female reproductive system and on male and couple fertility.ConclusionOverall, these data show that, after 2 years of COVID-19 vaccines, the endocrine system is not heavily threatened.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.